Mar. 4 at 9:20 PM
$SLS The Positive Phase 3 Registrational Results will give Gps the Fda Green light to treat 100,000 AML patients currently in remission - CCo estimated
$280K on patent, orphan drug rev per patient + 40k to 50K new patients Each Year.
- its a
$28B TAM - Worth Tens of Billions to Big Pharma.
SLS should do a full double up to
$10/
$12 per share in the Next Days as we Expect the Top Line Results ANY DAY NOW - and then the share price Launches.
$ABVX was
$5 stock, it doubled to
$10 approaching the P3 News - the PR Hit along with a T1 Trading Halt and a +600% Gap UP to
$60 to Open - and it KEPT on Climbing to a High of
$148 Some thing similar will be happening here.
$ABBV Buyout in the triple digits ... MO
